NCT06487832View on ClinicalTrials.gov

Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2027

Conditions
Normal WeightOverweight and ObesityInsulin SensitivityInsulin Resistance
Interventions
OTHER

Subcutaneous GLP1-RA

Subcutaneous administration of semaglutide

OTHER

Subcutaneous placebo

Subcutaneous administration of NaCl

Trial Locations (1)

72076

RECRUITING

University Clinic Tubingen, Department of Internal Medicine IV, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER